nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—AHR—breast cancer	0.363	0.835	CbGaD
Nimodipine—CYP3A4—breast cancer	0.0719	0.165	CbGaD
Nimodipine—CYP3A5—Lapatinib—breast cancer	0.0299	0.12	CbGbCtD
Nimodipine—CYP3A4—Exemestane—breast cancer	0.0231	0.0922	CbGbCtD
Nimodipine—CYP3A4—Letrozole—breast cancer	0.0196	0.0784	CbGbCtD
Nimodipine—CYP3A4—Anastrozole—breast cancer	0.0175	0.0699	CbGbCtD
Nimodipine—CYP3A4—Toremifene—breast cancer	0.016	0.0639	CbGbCtD
Nimodipine—CYP3A5—Tamoxifen—breast cancer	0.015	0.0599	CbGbCtD
Nimodipine—CYP3A4—Fulvestrant—breast cancer	0.0149	0.0594	CbGbCtD
Nimodipine—CYP3A4—Thiotepa—breast cancer	0.0133	0.053	CbGbCtD
Nimodipine—CYP3A4—Ixabepilone—breast cancer	0.0121	0.0484	CbGbCtD
Nimodipine—CYP3A4—Lapatinib—breast cancer	0.0117	0.0466	CbGbCtD
Nimodipine—CYP3A5—Paclitaxel—breast cancer	0.0117	0.0466	CbGbCtD
Nimodipine—CYP3A5—Irinotecan—breast cancer	0.0115	0.046	CbGbCtD
Nimodipine—CYP3A4—Raloxifene—breast cancer	0.00885	0.0353	CbGbCtD
Nimodipine—CYP3A5—Docetaxel—breast cancer	0.00844	0.0337	CbGbCtD
Nimodipine—CYP3A4—Vinorelbine—breast cancer	0.00648	0.0259	CbGbCtD
Nimodipine—CYP3A4—Tamoxifen—breast cancer	0.00585	0.0233	CbGbCtD
Nimodipine—CYP3A4—Mitoxantrone—breast cancer	0.0057	0.0228	CbGbCtD
Nimodipine—CYP3A4—Paclitaxel—breast cancer	0.00455	0.0182	CbGbCtD
Nimodipine—CYP3A4—Irinotecan—breast cancer	0.00449	0.0179	CbGbCtD
Nimodipine—CYP3A4—Vinblastine—breast cancer	0.00399	0.0159	CbGbCtD
Nimodipine—CYP3A4—Docetaxel—breast cancer	0.00329	0.0131	CbGbCtD
Nimodipine—CACNB4—nipple—breast cancer	0.00297	0.064	CbGeAlD
Nimodipine—CACNB3—mammary gland—breast cancer	0.00275	0.0593	CbGeAlD
Nimodipine—CYP3A4—Doxorubicin—breast cancer	0.00245	0.00979	CbGbCtD
Nimodipine—CACNB3—nipple—breast cancer	0.00227	0.0491	CbGeAlD
Nimodipine—AHR—nipple—breast cancer	0.00169	0.0363	CbGeAlD
Nimodipine—CACNB3—endometrium—breast cancer	0.00137	0.0296	CbGeAlD
Nimodipine—CACNB1—adipose tissue—breast cancer	0.00129	0.0278	CbGeAlD
Nimodipine—CACNB3—uterus—breast cancer	0.00127	0.0273	CbGeAlD
Nimodipine—CACNB3—pituitary gland—breast cancer	0.00124	0.0268	CbGeAlD
Nimodipine—CACNB3—adipose tissue—breast cancer	0.00124	0.0267	CbGeAlD
Nimodipine—CACNB1—adrenal gland—breast cancer	0.00116	0.025	CbGeAlD
Nimodipine—CACNB3—female reproductive system—breast cancer	0.00114	0.0245	CbGeAlD
Nimodipine—NR3C2—nipple—breast cancer	0.00112	0.0242	CbGeAlD
Nimodipine—CACNB3—adrenal gland—breast cancer	0.00111	0.0239	CbGeAlD
Nimodipine—CACNB1—female gonad—breast cancer	0.00108	0.0233	CbGeAlD
Nimodipine—CACNB3—female gonad—breast cancer	0.00104	0.0223	CbGeAlD
Nimodipine—AHR—endometrium—breast cancer	0.00102	0.0219	CbGeAlD
Nimodipine—AHR—uterus—breast cancer	0.000938	0.0202	CbGeAlD
Nimodipine—AHR—pituitary gland—breast cancer	0.000921	0.0199	CbGeAlD
Nimodipine—AHR—adipose tissue—breast cancer	0.000917	0.0198	CbGeAlD
Nimodipine—AHR—female reproductive system—breast cancer	0.000843	0.0182	CbGeAlD
Nimodipine—CACNB2—pituitary gland—breast cancer	0.000835	0.018	CbGeAlD
Nimodipine—AHR—adrenal gland—breast cancer	0.000822	0.0177	CbGeAlD
Nimodipine—AHR—bone marrow—breast cancer	0.000796	0.0172	CbGeAlD
Nimodipine—AHR—female gonad—breast cancer	0.000767	0.0165	CbGeAlD
Nimodipine—CACNB2—adrenal gland—breast cancer	0.000746	0.0161	CbGeAlD
Nimodipine—CACNA1D—pituitary gland—breast cancer	0.00073	0.0157	CbGeAlD
Nimodipine—AHR—endocrine gland—breast cancer	0.000713	0.0154	CbGeAlD
Nimodipine—CACNB1—lymph node—breast cancer	0.000694	0.015	CbGeAlD
Nimodipine—NR3C2—endometrium—breast cancer	0.000678	0.0146	CbGeAlD
Nimodipine—CACNA1C—pituitary gland—breast cancer	0.000674	0.0145	CbGeAlD
Nimodipine—CACNA1C—adipose tissue—breast cancer	0.000671	0.0145	CbGeAlD
Nimodipine—CACNB3—lymph node—breast cancer	0.000666	0.0144	CbGeAlD
Nimodipine—CACNA1D—adrenal gland—breast cancer	0.000652	0.0141	CbGeAlD
Nimodipine—NR3C2—uterus—breast cancer	0.000624	0.0135	CbGeAlD
Nimodipine—CACNA1C—female reproductive system—breast cancer	0.000617	0.0133	CbGeAlD
Nimodipine—NR3C2—pituitary gland—breast cancer	0.000613	0.0132	CbGeAlD
Nimodipine—NR3C2—adipose tissue—breast cancer	0.000611	0.0132	CbGeAlD
Nimodipine—CACNA1C—adrenal gland—breast cancer	0.000602	0.013	CbGeAlD
Nimodipine—CACNA1D—endocrine gland—breast cancer	0.000565	0.0122	CbGeAlD
Nimodipine—NR3C2—female reproductive system—breast cancer	0.000561	0.0121	CbGeAlD
Nimodipine—NR3C2—adrenal gland—breast cancer	0.000548	0.0118	CbGeAlD
Nimodipine—CACNA1C—endocrine gland—breast cancer	0.000522	0.0113	CbGeAlD
Nimodipine—NR3C2—female gonad—breast cancer	0.000511	0.011	CbGeAlD
Nimodipine—AHR—lymph node—breast cancer	0.000493	0.0106	CbGeAlD
Nimodipine—NR3C2—endocrine gland—breast cancer	0.000475	0.0102	CbGeAlD
Nimodipine—CACNB2—lymph node—breast cancer	0.000447	0.00964	CbGeAlD
Nimodipine—CACNA1D—lymph node—breast cancer	0.000391	0.00843	CbGeAlD
Nimodipine—CACNA1C—lymph node—breast cancer	0.000361	0.00778	CbGeAlD
Nimodipine—CYP3A5—adipose tissue—breast cancer	0.00033	0.00712	CbGeAlD
Nimodipine—NR3C2—lymph node—breast cancer	0.000328	0.00708	CbGeAlD
Nimodipine—CYP3A5—female gonad—breast cancer	0.000276	0.00596	CbGeAlD
Nimodipine—Clevidipine—BCHE—breast cancer	0.000269	0.0912	CrCbGaD
Nimodipine—CYP3A5—endocrine gland—breast cancer	0.000257	0.00554	CbGeAlD
Nimodipine—CYP3A4—female reproductive system—breast cancer	0.000228	0.00491	CbGeAlD
Nimodipine—CYP3A4—endocrine gland—breast cancer	0.000193	0.00416	CbGeAlD
Nimodipine—Lercanidipine—CYP2D6—breast cancer	0.000185	0.0628	CrCbGaD
Nimodipine—Lercanidipine—CYP3A4—breast cancer	0.000159	0.0539	CrCbGaD
Nimodipine—Amlodipine—CYP1A1—breast cancer	0.000153	0.0519	CrCbGaD
Nimodipine—Clevidipine—CYP2D6—breast cancer	0.000148	0.05	CrCbGaD
Nimodipine—Isradipine—CYP3A4—breast cancer	0.000144	0.0488	CrCbGaD
Nimodipine—Nifedipine—CYP1A1—breast cancer	0.000137	0.0464	CrCbGaD
Nimodipine—Clevidipine—CYP3A4—breast cancer	0.000127	0.0429	CrCbGaD
Nimodipine—Nisoldipine—CYP3A4—breast cancer	0.000121	0.0411	CrCbGaD
Nimodipine—Tachycardia—Fluorouracil—breast cancer	0.000116	0.000814	CcSEcCtD
Nimodipine—Hypotension—Irinotecan—breast cancer	0.000116	0.000814	CcSEcCtD
Nimodipine—Hypotension—Mitoxantrone—breast cancer	0.000116	0.000814	CcSEcCtD
Nimodipine—Vomiting—Vinblastine—breast cancer	0.000115	0.000808	CcSEcCtD
Nimodipine—Diarrhoea—Goserelin—breast cancer	0.000115	0.000807	CcSEcCtD
Nimodipine—Anaemia—Paclitaxel—breast cancer	0.000115	0.000804	CcSEcCtD
Nimodipine—Amlodipine—CYP2D6—breast cancer	0.000114	0.0386	CrCbGaD
Nimodipine—Nitrendipine—CYP3A4—breast cancer	0.000114	0.0385	CrCbGaD
Nimodipine—Nilvadipine—CYP3A4—breast cancer	0.000114	0.0385	CrCbGaD
Nimodipine—Headache—Vinblastine—breast cancer	0.000113	0.000796	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000113	0.000794	CcSEcCtD
Nimodipine—Hypotension—Gemcitabine—breast cancer	0.000113	0.000793	CcSEcCtD
Nimodipine—Cardiac disorder—Docetaxel—breast cancer	0.000112	0.000787	CcSEcCtD
Nimodipine—Flushing—Docetaxel—breast cancer	0.000112	0.000787	CcSEcCtD
Nimodipine—Vomiting—Tamoxifen—breast cancer	0.000112	0.000785	CcSEcCtD
Nimodipine—Dizziness—Goserelin—breast cancer	0.000111	0.00078	CcSEcCtD
Nimodipine—Hypotension—Fluorouracil—breast cancer	0.000111	0.00078	CcSEcCtD
Nimodipine—Rash—Tamoxifen—breast cancer	0.000111	0.000778	CcSEcCtD
Nimodipine—Hypersensitivity—Vinorelbine—breast cancer	0.000111	0.000778	CcSEcCtD
Nimodipine—Dermatitis—Tamoxifen—breast cancer	0.000111	0.000778	CcSEcCtD
Nimodipine—Dyspnoea—Irinotecan—breast cancer	0.000111	0.000777	CcSEcCtD
Nimodipine—Dyspnoea—Mitoxantrone—breast cancer	0.000111	0.000777	CcSEcCtD
Nimodipine—Headache—Tamoxifen—breast cancer	0.00011	0.000773	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.00011	0.000773	CcSEcCtD
Nimodipine—Palpitations—Paclitaxel—breast cancer	0.00011	0.000769	CcSEcCtD
Nimodipine—Angiopathy—Docetaxel—breast cancer	0.000109	0.000769	CcSEcCtD
Nimodipine—Vomiting—Melphalan—breast cancer	0.000109	0.000769	CcSEcCtD
Nimodipine—Hyponatraemia—Doxorubicin—breast cancer	0.000109	0.000768	CcSEcCtD
Nimodipine—Immune system disorder—Docetaxel—breast cancer	0.000109	0.000766	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	0.000109	0.000765	CcSEcCtD
Nimodipine—Liver function test abnormal—Epirubicin—breast cancer	0.000109	0.000763	CcSEcCtD
Nimodipine—Rash—Melphalan—breast cancer	0.000109	0.000762	CcSEcCtD
Nimodipine—Flushing—Capecitabine—breast cancer	0.000108	0.000762	CcSEcCtD
Nimodipine—Cardiac disorder—Capecitabine—breast cancer	0.000108	0.000762	CcSEcCtD
Nimodipine—Dermatitis—Melphalan—breast cancer	0.000108	0.000762	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000108	0.00076	CcSEcCtD
Nimodipine—Dyspnoea—Gemcitabine—breast cancer	0.000108	0.000756	CcSEcCtD
Nimodipine—Nausea—Vinblastine—breast cancer	0.000107	0.000755	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Irinotecan—breast cancer	0.000107	0.000752	CcSEcCtD
Nimodipine—Hypertension—Paclitaxel—breast cancer	0.000107	0.000751	CcSEcCtD
Nimodipine—Vomiting—Goserelin—breast cancer	0.000107	0.00075	CcSEcCtD
Nimodipine—Pruritus—Vinorelbine—breast cancer	0.000106	0.000747	CcSEcCtD
Nimodipine—Angiopathy—Capecitabine—breast cancer	0.000106	0.000744	CcSEcCtD
Nimodipine—Dyspnoea—Fluorouracil—breast cancer	0.000106	0.000744	CcSEcCtD
Nimodipine—Rash—Goserelin—breast cancer	0.000106	0.000744	CcSEcCtD
Nimodipine—Hypersensitivity—Thiotepa—breast cancer	0.000106	0.000743	CcSEcCtD
Nimodipine—Dermatitis—Goserelin—breast cancer	0.000106	0.000743	CcSEcCtD
Nimodipine—Immune system disorder—Capecitabine—breast cancer	0.000106	0.000741	CcSEcCtD
Nimodipine—Myalgia—Paclitaxel—breast cancer	0.000105	0.000741	CcSEcCtD
Nimodipine—Felodipine—CYP2D6—breast cancer	0.000105	0.0357	CrCbGaD
Nimodipine—Headache—Goserelin—breast cancer	0.000105	0.000739	CcSEcCtD
Nimodipine—Nausea—Tamoxifen—breast cancer	0.000104	0.000733	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000104	0.000733	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Epirubicin—breast cancer	0.000104	0.000729	CcSEcCtD
Nimodipine—Diarrhoea—Vinorelbine—breast cancer	0.000103	0.000723	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000103	0.00072	CcSEcCtD
Nimodipine—Nausea—Melphalan—breast cancer	0.000102	0.000718	CcSEcCtD
Nimodipine—Nifedipine—CYP2D6—breast cancer	0.000102	0.0345	CrCbGaD
Nimodipine—Pruritus—Thiotepa—breast cancer	0.000102	0.000714	CcSEcCtD
Nimodipine—Oedema—Paclitaxel—breast cancer	0.000101	0.00071	CcSEcCtD
Nimodipine—Nisoldipine—ABCB1—breast cancer	0.000101	0.0343	CrCbGaD
Nimodipine—Muscle spasms—Docetaxel—breast cancer	0.000101	0.000709	CcSEcCtD
Nimodipine—Liver function test abnormal—Doxorubicin—breast cancer	0.0001	0.000706	CcSEcCtD
Nimodipine—Nicardipine—CYP2D6—breast cancer	0.0001	0.034	CrCbGaD
Nimodipine—Nausea—Goserelin—breast cancer	9.97e-05	0.0007	CcSEcCtD
Nimodipine—Dizziness—Vinorelbine—breast cancer	9.94e-05	0.000698	CcSEcCtD
Nimodipine—Nervous system disorder—Paclitaxel—breast cancer	9.92e-05	0.000697	CcSEcCtD
Nimodipine—Thrombocytopenia—Paclitaxel—breast cancer	9.9e-05	0.000696	CcSEcCtD
Nimodipine—Tachycardia—Paclitaxel—breast cancer	9.87e-05	0.000693	CcSEcCtD
Nimodipine—Diarrhoea—Thiotepa—breast cancer	9.82e-05	0.00069	CcSEcCtD
Nimodipine—Amlodipine—CYP3A4—breast cancer	9.78e-05	0.0331	CrCbGaD
Nimodipine—Muscle spasms—Capecitabine—breast cancer	9.78e-05	0.000687	CcSEcCtD
Nimodipine—Hyperhidrosis—Paclitaxel—breast cancer	9.78e-05	0.000687	CcSEcCtD
Nimodipine—Anaemia—Docetaxel—breast cancer	9.71e-05	0.000682	CcSEcCtD
Nimodipine—Depression—Methotrexate—breast cancer	9.66e-05	0.000678	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—breast cancer	9.6e-05	0.000674	CcSEcCtD
Nimodipine—Vomiting—Vinorelbine—breast cancer	9.56e-05	0.000672	CcSEcCtD
Nimodipine—Dizziness—Thiotepa—breast cancer	9.5e-05	0.000667	CcSEcCtD
Nimodipine—Rash—Vinorelbine—breast cancer	9.48e-05	0.000666	CcSEcCtD
Nimodipine—Dermatitis—Vinorelbine—breast cancer	9.47e-05	0.000665	CcSEcCtD
Nimodipine—Nitrendipine—ABCB1—breast cancer	9.45e-05	0.032	CrCbGaD
Nimodipine—Hypotension—Paclitaxel—breast cancer	9.45e-05	0.000664	CcSEcCtD
Nimodipine—Headache—Vinorelbine—breast cancer	9.42e-05	0.000662	CcSEcCtD
Nimodipine—Anaemia—Capecitabine—breast cancer	9.4e-05	0.00066	CcSEcCtD
Nimodipine—Palpitations—Docetaxel—breast cancer	9.28e-05	0.000652	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Paclitaxel—breast cancer	9.21e-05	0.000647	CcSEcCtD
Nimodipine—Hepatobiliary disease—Methotrexate—breast cancer	9.16e-05	0.000644	CcSEcCtD
Nimodipine—Hypersensitivity—Mitoxantrone—breast cancer	9.14e-05	0.000642	CcSEcCtD
Nimodipine—Hypersensitivity—Irinotecan—breast cancer	9.14e-05	0.000642	CcSEcCtD
Nimodipine—Vomiting—Thiotepa—breast cancer	9.13e-05	0.000641	CcSEcCtD
Nimodipine—Hypertension—Docetaxel—breast cancer	9.07e-05	0.000637	CcSEcCtD
Nimodipine—Rash—Thiotepa—breast cancer	9.05e-05	0.000636	CcSEcCtD
Nimodipine—Dermatitis—Thiotepa—breast cancer	9.05e-05	0.000635	CcSEcCtD
Nimodipine—Felodipine—CYP3A4—breast cancer	9.04e-05	0.0306	CrCbGaD
Nimodipine—Dyspnoea—Paclitaxel—breast cancer	9.02e-05	0.000633	CcSEcCtD
Nimodipine—Headache—Thiotepa—breast cancer	9e-05	0.000632	CcSEcCtD
Nimodipine—Palpitations—Capecitabine—breast cancer	8.99e-05	0.000631	CcSEcCtD
Nimodipine—Myalgia—Docetaxel—breast cancer	8.94e-05	0.000628	CcSEcCtD
Nimodipine—Nausea—Vinorelbine—breast cancer	8.93e-05	0.000627	CcSEcCtD
Nimodipine—Jaundice—Epirubicin—breast cancer	8.84e-05	0.000621	CcSEcCtD
Nimodipine—Hypertension—Capecitabine—breast cancer	8.78e-05	0.000617	CcSEcCtD
Nimodipine—Hypersensitivity—Fluorouracil—breast cancer	8.75e-05	0.000615	CcSEcCtD
Nimodipine—Nifedipine—CYP3A4—breast cancer	8.74e-05	0.0296	CrCbGaD
Nimodipine—Gastrointestinal disorder—Paclitaxel—breast cancer	8.73e-05	0.000613	CcSEcCtD
Nimodipine—Hepatitis—Methotrexate—breast cancer	8.7e-05	0.000611	CcSEcCtD
Nimodipine—Myalgia—Capecitabine—breast cancer	8.66e-05	0.000608	CcSEcCtD
Nimodipine—Nicardipine—CYP3A4—breast cancer	8.61e-05	0.0292	CrCbGaD
Nimodipine—Hepatobiliary disease—Epirubicin—breast cancer	8.57e-05	0.000602	CcSEcCtD
Nimodipine—Oedema—Docetaxel—breast cancer	8.57e-05	0.000602	CcSEcCtD
Nimodipine—Pruritus—Gemcitabine—breast cancer	8.55e-05	0.0006	CcSEcCtD
Nimodipine—Nausea—Thiotepa—breast cancer	8.53e-05	0.000599	CcSEcCtD
Nimodipine—Diarrhoea—Mitoxantrone—breast cancer	8.48e-05	0.000596	CcSEcCtD
Nimodipine—Diarrhoea—Irinotecan—breast cancer	8.48e-05	0.000596	CcSEcCtD
Nimodipine—Nervous system disorder—Docetaxel—breast cancer	8.41e-05	0.00059	CcSEcCtD
Nimodipine—Pruritus—Fluorouracil—breast cancer	8.4e-05	0.00059	CcSEcCtD
Nimodipine—Thrombocytopenia—Docetaxel—breast cancer	8.39e-05	0.00059	CcSEcCtD
Nimodipine—Tachycardia—Docetaxel—breast cancer	8.37e-05	0.000588	CcSEcCtD
Nimodipine—Oedema—Capecitabine—breast cancer	8.3e-05	0.000583	CcSEcCtD
Nimodipine—Bradycardia—Epirubicin—breast cancer	8.29e-05	0.000582	CcSEcCtD
Nimodipine—Diarrhoea—Gemcitabine—breast cancer	8.26e-05	0.000581	CcSEcCtD
Nimodipine—Dizziness—Irinotecan—breast cancer	8.2e-05	0.000576	CcSEcCtD
Nimodipine—Jaundice—Doxorubicin—breast cancer	8.18e-05	0.000574	CcSEcCtD
Nimodipine—Amlodipine—ABCB1—breast cancer	8.14e-05	0.0276	CrCbGaD
Nimodipine—Nervous system disorder—Capecitabine—breast cancer	8.14e-05	0.000572	CcSEcCtD
Nimodipine—Hepatitis—Epirubicin—breast cancer	8.14e-05	0.000572	CcSEcCtD
Nimodipine—Diarrhoea—Fluorouracil—breast cancer	8.13e-05	0.000571	CcSEcCtD
Nimodipine—Thrombocytopenia—Capecitabine—breast cancer	8.13e-05	0.000571	CcSEcCtD
Nimodipine—Tachycardia—Capecitabine—breast cancer	8.1e-05	0.000569	CcSEcCtD
Nimodipine—Cardiac disorder—Methotrexate—breast cancer	8.07e-05	0.000567	CcSEcCtD
Nimodipine—Hyperhidrosis—Capecitabine—breast cancer	8.02e-05	0.000564	CcSEcCtD
Nimodipine—Hypotension—Docetaxel—breast cancer	8.01e-05	0.000563	CcSEcCtD
Nimodipine—Hepatobiliary disease—Doxorubicin—breast cancer	7.93e-05	0.000557	CcSEcCtD
Nimodipine—Angiopathy—Methotrexate—breast cancer	7.89e-05	0.000554	CcSEcCtD
Nimodipine—Vomiting—Mitoxantrone—breast cancer	7.88e-05	0.000554	CcSEcCtD
Nimodipine—Vomiting—Irinotecan—breast cancer	7.88e-05	0.000554	CcSEcCtD
Nimodipine—Immune system disorder—Methotrexate—breast cancer	7.85e-05	0.000552	CcSEcCtD
Nimodipine—Dizziness—Fluorouracil—breast cancer	7.85e-05	0.000552	CcSEcCtD
Nimodipine—Rash—Mitoxantrone—breast cancer	7.82e-05	0.000549	CcSEcCtD
Nimodipine—Rash—Irinotecan—breast cancer	7.82e-05	0.000549	CcSEcCtD
Nimodipine—Dermatitis—Mitoxantrone—breast cancer	7.81e-05	0.000549	CcSEcCtD
Nimodipine—Dermatitis—Irinotecan—breast cancer	7.81e-05	0.000549	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Docetaxel—breast cancer	7.81e-05	0.000549	CcSEcCtD
Nimodipine—Headache—Mitoxantrone—breast cancer	7.77e-05	0.000546	CcSEcCtD
Nimodipine—Headache—Irinotecan—breast cancer	7.77e-05	0.000546	CcSEcCtD
Nimodipine—Hypotension—Capecitabine—breast cancer	7.76e-05	0.000545	CcSEcCtD
Nimodipine—Vomiting—Gemcitabine—breast cancer	7.68e-05	0.000539	CcSEcCtD
Nimodipine—Bradycardia—Doxorubicin—breast cancer	7.67e-05	0.000538	CcSEcCtD
Nimodipine—Dyspnoea—Docetaxel—breast cancer	7.64e-05	0.000537	CcSEcCtD
Nimodipine—Rash—Gemcitabine—breast cancer	7.62e-05	0.000535	CcSEcCtD
Nimodipine—Dermatitis—Gemcitabine—breast cancer	7.61e-05	0.000534	CcSEcCtD
Nimodipine—Headache—Gemcitabine—breast cancer	7.57e-05	0.000532	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Capecitabine—breast cancer	7.56e-05	0.000531	CcSEcCtD
Nimodipine—Flushing—Epirubicin—breast cancer	7.55e-05	0.000531	CcSEcCtD
Nimodipine—Cardiac disorder—Epirubicin—breast cancer	7.55e-05	0.000531	CcSEcCtD
Nimodipine—Vomiting—Fluorouracil—breast cancer	7.55e-05	0.00053	CcSEcCtD
Nimodipine—Hepatitis—Doxorubicin—breast cancer	7.53e-05	0.000529	CcSEcCtD
Nimodipine—Felodipine—ABCB1—breast cancer	7.53e-05	0.0255	CrCbGaD
Nimodipine—Rash—Fluorouracil—breast cancer	7.49e-05	0.000526	CcSEcCtD
Nimodipine—Dermatitis—Fluorouracil—breast cancer	7.48e-05	0.000526	CcSEcCtD
Nimodipine—Hypersensitivity—Paclitaxel—breast cancer	7.45e-05	0.000523	CcSEcCtD
Nimodipine—Headache—Fluorouracil—breast cancer	7.44e-05	0.000523	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Docetaxel—breast cancer	7.4e-05	0.00052	CcSEcCtD
Nimodipine—Dyspnoea—Capecitabine—breast cancer	7.4e-05	0.00052	CcSEcCtD
Nimodipine—Angiopathy—Epirubicin—breast cancer	7.38e-05	0.000519	CcSEcCtD
Nimodipine—Nausea—Mitoxantrone—breast cancer	7.37e-05	0.000517	CcSEcCtD
Nimodipine—Nausea—Irinotecan—breast cancer	7.37e-05	0.000517	CcSEcCtD
Nimodipine—Immune system disorder—Epirubicin—breast cancer	7.35e-05	0.000516	CcSEcCtD
Nimodipine—Nifedipine—ABCB1—breast cancer	7.28e-05	0.0247	CrCbGaD
Nimodipine—Nausea—Gemcitabine—breast cancer	7.18e-05	0.000504	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Capecitabine—breast cancer	7.17e-05	0.000503	CcSEcCtD
Nimodipine—Nicardipine—ABCB1—breast cancer	7.17e-05	0.0243	CrCbGaD
Nimodipine—Pruritus—Paclitaxel—breast cancer	7.16e-05	0.000503	CcSEcCtD
Nimodipine—Nausea—Fluorouracil—breast cancer	7.05e-05	0.000496	CcSEcCtD
Nimodipine—Anaemia—Methotrexate—breast cancer	7e-05	0.000491	CcSEcCtD
Nimodipine—Flushing—Doxorubicin—breast cancer	6.99e-05	0.000491	CcSEcCtD
Nimodipine—Cardiac disorder—Doxorubicin—breast cancer	6.99e-05	0.000491	CcSEcCtD
Nimodipine—Diarrhoea—Paclitaxel—breast cancer	6.92e-05	0.000486	CcSEcCtD
Nimodipine—Angiopathy—Doxorubicin—breast cancer	6.83e-05	0.00048	CcSEcCtD
Nimodipine—Muscle spasms—Epirubicin—breast cancer	6.81e-05	0.000478	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—breast cancer	6.8e-05	0.000478	CcSEcCtD
Nimodipine—Dizziness—Paclitaxel—breast cancer	6.69e-05	0.00047	CcSEcCtD
Nimodipine—Anaemia—Epirubicin—breast cancer	6.55e-05	0.00046	CcSEcCtD
Nimodipine—Myalgia—Methotrexate—breast cancer	6.45e-05	0.000453	CcSEcCtD
Nimodipine—Vomiting—Paclitaxel—breast cancer	6.43e-05	0.000452	CcSEcCtD
Nimodipine—Rash—Paclitaxel—breast cancer	6.38e-05	0.000448	CcSEcCtD
Nimodipine—Dermatitis—Paclitaxel—breast cancer	6.37e-05	0.000447	CcSEcCtD
Nimodipine—Headache—Paclitaxel—breast cancer	6.34e-05	0.000445	CcSEcCtD
Nimodipine—Hypersensitivity—Docetaxel—breast cancer	6.32e-05	0.000444	CcSEcCtD
Nimodipine—Muscle spasms—Doxorubicin—breast cancer	6.3e-05	0.000443	CcSEcCtD
Nimodipine—Palpitations—Epirubicin—breast cancer	6.26e-05	0.00044	CcSEcCtD
Nimodipine—Hypertension—Epirubicin—breast cancer	6.12e-05	0.00043	CcSEcCtD
Nimodipine—Hypersensitivity—Capecitabine—breast cancer	6.11e-05	0.00043	CcSEcCtD
Nimodipine—Pruritus—Docetaxel—breast cancer	6.06e-05	0.000426	CcSEcCtD
Nimodipine—Nervous system disorder—Methotrexate—breast cancer	6.06e-05	0.000426	CcSEcCtD
Nimodipine—Anaemia—Doxorubicin—breast cancer	6.06e-05	0.000426	CcSEcCtD
Nimodipine—Thrombocytopenia—Methotrexate—breast cancer	6.05e-05	0.000425	CcSEcCtD
Nimodipine—Myalgia—Epirubicin—breast cancer	6.03e-05	0.000424	CcSEcCtD
Nimodipine—Nausea—Paclitaxel—breast cancer	6.01e-05	0.000422	CcSEcCtD
Nimodipine—Hyperhidrosis—Methotrexate—breast cancer	5.97e-05	0.00042	CcSEcCtD
Nimodipine—Pruritus—Capecitabine—breast cancer	5.87e-05	0.000412	CcSEcCtD
Nimodipine—Diarrhoea—Docetaxel—breast cancer	5.87e-05	0.000412	CcSEcCtD
Nimodipine—Palpitations—Doxorubicin—breast cancer	5.79e-05	0.000407	CcSEcCtD
Nimodipine—Oedema—Epirubicin—breast cancer	5.78e-05	0.000406	CcSEcCtD
Nimodipine—Hypotension—Methotrexate—breast cancer	5.77e-05	0.000406	CcSEcCtD
Nimodipine—Diarrhoea—Capecitabine—breast cancer	5.68e-05	0.000399	CcSEcCtD
Nimodipine—Nervous system disorder—Epirubicin—breast cancer	5.67e-05	0.000398	CcSEcCtD
Nimodipine—Dizziness—Docetaxel—breast cancer	5.67e-05	0.000398	CcSEcCtD
Nimodipine—Thrombocytopenia—Epirubicin—breast cancer	5.66e-05	0.000398	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—breast cancer	5.66e-05	0.000398	CcSEcCtD
Nimodipine—Tachycardia—Epirubicin—breast cancer	5.64e-05	0.000396	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methotrexate—breast cancer	5.63e-05	0.000395	CcSEcCtD
Nimodipine—Hyperhidrosis—Epirubicin—breast cancer	5.59e-05	0.000393	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—breast cancer	5.58e-05	0.000392	CcSEcCtD
Nimodipine—Dyspnoea—Methotrexate—breast cancer	5.51e-05	0.000387	CcSEcCtD
Nimodipine—Dizziness—Capecitabine—breast cancer	5.49e-05	0.000386	CcSEcCtD
Nimodipine—Vomiting—Docetaxel—breast cancer	5.45e-05	0.000383	CcSEcCtD
Nimodipine—Rash—Docetaxel—breast cancer	5.4e-05	0.00038	CcSEcCtD
Nimodipine—Hypotension—Epirubicin—breast cancer	5.4e-05	0.000379	CcSEcCtD
Nimodipine—Dermatitis—Docetaxel—breast cancer	5.4e-05	0.000379	CcSEcCtD
Nimodipine—Headache—Docetaxel—breast cancer	5.37e-05	0.000377	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—breast cancer	5.35e-05	0.000376	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Methotrexate—breast cancer	5.33e-05	0.000375	CcSEcCtD
Nimodipine—Vomiting—Capecitabine—breast cancer	5.28e-05	0.000371	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Epirubicin—breast cancer	5.27e-05	0.00037	CcSEcCtD
Nimodipine—Nervous system disorder—Doxorubicin—breast cancer	5.25e-05	0.000369	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—breast cancer	5.24e-05	0.000368	CcSEcCtD
Nimodipine—Rash—Capecitabine—breast cancer	5.23e-05	0.000368	CcSEcCtD
Nimodipine—Dermatitis—Capecitabine—breast cancer	5.23e-05	0.000367	CcSEcCtD
Nimodipine—Tachycardia—Doxorubicin—breast cancer	5.22e-05	0.000367	CcSEcCtD
Nimodipine—Headache—Capecitabine—breast cancer	5.2e-05	0.000365	CcSEcCtD
Nimodipine—Hyperhidrosis—Doxorubicin—breast cancer	5.17e-05	0.000363	CcSEcCtD
Nimodipine—Dyspnoea—Epirubicin—breast cancer	5.15e-05	0.000362	CcSEcCtD
Nimodipine—Nausea—Docetaxel—breast cancer	5.09e-05	0.000358	CcSEcCtD
Nimodipine—Hypotension—Doxorubicin—breast cancer	5e-05	0.000351	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Epirubicin—breast cancer	4.99e-05	0.000351	CcSEcCtD
Nimodipine—Nausea—Capecitabine—breast cancer	4.93e-05	0.000346	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.87e-05	0.000342	CcSEcCtD
Nimodipine—Dyspnoea—Doxorubicin—breast cancer	4.77e-05	0.000335	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Doxorubicin—breast cancer	4.62e-05	0.000324	CcSEcCtD
Nimodipine—Hypersensitivity—Methotrexate—breast cancer	4.55e-05	0.00032	CcSEcCtD
Nimodipine—Pruritus—Methotrexate—breast cancer	4.37e-05	0.000307	CcSEcCtD
Nimodipine—Hypersensitivity—Epirubicin—breast cancer	4.26e-05	0.000299	CcSEcCtD
Nimodipine—Diarrhoea—Methotrexate—breast cancer	4.23e-05	0.000297	CcSEcCtD
Nimodipine—Pruritus—Epirubicin—breast cancer	4.09e-05	0.000287	CcSEcCtD
Nimodipine—Dizziness—Methotrexate—breast cancer	4.09e-05	0.000287	CcSEcCtD
Nimodipine—Diarrhoea—Epirubicin—breast cancer	3.96e-05	0.000278	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—breast cancer	3.94e-05	0.000277	CcSEcCtD
Nimodipine—Vomiting—Methotrexate—breast cancer	3.93e-05	0.000276	CcSEcCtD
Nimodipine—Rash—Methotrexate—breast cancer	3.9e-05	0.000274	CcSEcCtD
Nimodipine—Dermatitis—Methotrexate—breast cancer	3.89e-05	0.000273	CcSEcCtD
Nimodipine—Headache—Methotrexate—breast cancer	3.87e-05	0.000272	CcSEcCtD
Nimodipine—Dizziness—Epirubicin—breast cancer	3.82e-05	0.000269	CcSEcCtD
Nimodipine—Pruritus—Doxorubicin—breast cancer	3.79e-05	0.000266	CcSEcCtD
Nimodipine—Vomiting—Epirubicin—breast cancer	3.68e-05	0.000258	CcSEcCtD
Nimodipine—Nausea—Methotrexate—breast cancer	3.67e-05	0.000258	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—breast cancer	3.66e-05	0.000257	CcSEcCtD
Nimodipine—Rash—Epirubicin—breast cancer	3.65e-05	0.000256	CcSEcCtD
Nimodipine—Dermatitis—Epirubicin—breast cancer	3.64e-05	0.000256	CcSEcCtD
Nimodipine—Headache—Epirubicin—breast cancer	3.62e-05	0.000254	CcSEcCtD
Nimodipine—Dizziness—Doxorubicin—breast cancer	3.54e-05	0.000248	CcSEcCtD
Nimodipine—Nausea—Epirubicin—breast cancer	3.43e-05	0.000241	CcSEcCtD
Nimodipine—Vomiting—Doxorubicin—breast cancer	3.4e-05	0.000239	CcSEcCtD
Nimodipine—Rash—Doxorubicin—breast cancer	3.37e-05	0.000237	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—breast cancer	3.37e-05	0.000237	CcSEcCtD
Nimodipine—Headache—Doxorubicin—breast cancer	3.35e-05	0.000235	CcSEcCtD
Nimodipine—Nausea—Doxorubicin—breast cancer	3.18e-05	0.000223	CcSEcCtD
Nimodipine—CACNA1D—Metabolism—TYMS—breast cancer	8.12e-06	6.62e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GPX1—breast cancer	8.12e-06	6.62e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—breast cancer	8.11e-06	6.61e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SRC—breast cancer	8.08e-06	6.59e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—breast cancer	8.06e-06	6.58e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP1A1—breast cancer	8.04e-06	6.56e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—breast cancer	8.04e-06	6.56e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP1A1—breast cancer	8.03e-06	6.55e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NCOR1—breast cancer	8.03e-06	6.54e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PLA2G4A—breast cancer	8.03e-06	6.54e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTM1—breast cancer	8.03e-06	6.54e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ADSL—breast cancer	8e-06	6.52e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PHGDH—breast cancer	8e-06	6.52e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—UMPS—breast cancer	8e-06	6.52e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NME1—breast cancer	8e-06	6.52e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—FHL2—breast cancer	8e-06	6.52e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—breast cancer	7.98e-06	6.5e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—breast cancer	7.97e-06	6.5e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ERCC2—breast cancer	7.97e-06	6.5e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	7.93e-06	6.47e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CB—breast cancer	7.89e-06	6.44e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—breast cancer	7.87e-06	6.42e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HPSE—breast cancer	7.84e-06	6.39e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BRIP1—breast cancer	7.84e-06	6.39e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LDHB—breast cancer	7.84e-06	6.39e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—breast cancer	7.82e-06	6.38e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—breast cancer	7.8e-06	6.36e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—COMT—breast cancer	7.71e-06	6.29e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GPX1—breast cancer	7.69e-06	6.27e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—breast cancer	7.68e-06	6.26e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTP1—breast cancer	7.67e-06	6.26e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—breast cancer	7.63e-06	6.22e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—breast cancer	7.63e-06	6.22e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—breast cancer	7.62e-06	6.21e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1A1—breast cancer	7.61e-06	6.2e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HMOX1—breast cancer	7.57e-06	6.17e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ITPR1—breast cancer	7.55e-06	6.16e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ERCC2—breast cancer	7.55e-06	6.15e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—breast cancer	7.49e-06	6.11e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK3—breast cancer	7.45e-06	6.07e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA3—breast cancer	7.43e-06	6.06e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HMMR—breast cancer	7.43e-06	6.06e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCC1—breast cancer	7.43e-06	6.06e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ABCB1—breast cancer	7.26e-06	5.92e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TGFB1—breast cancer	7.23e-06	5.89e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARGC1B—breast cancer	7.2e-06	5.87e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TYMS—breast cancer	7.13e-06	5.82e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—breast cancer	7.09e-06	5.78e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—breast cancer	7.09e-06	5.78e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PLA2G4A—breast cancer	7.05e-06	5.75e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—breast cancer	7.05e-06	5.75e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NCOR1—breast cancer	7.05e-06	5.75e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—breast cancer	7.04e-06	5.74e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CAV1—breast cancer	6.91e-06	5.63e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—breast cancer	6.84e-06	5.58e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTEN—breast cancer	6.82e-06	5.56e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA9—breast cancer	6.8e-06	5.54e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA4—breast cancer	6.8e-06	5.54e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GPX1—breast cancer	6.75e-06	5.51e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—breast cancer	6.75e-06	5.5e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MAPK3—breast cancer	6.73e-06	5.49e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—breast cancer	6.69e-06	5.46e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1A1—breast cancer	6.69e-06	5.45e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ERCC2—breast cancer	6.63e-06	5.41e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA2—breast cancer	6.63e-06	5.4e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPX2—breast cancer	6.63e-06	5.4e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—breast cancer	6.54e-06	5.34e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—breast cancer	6.54e-06	5.34e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPX4—breast cancer	6.54e-06	5.34e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SULT1A1—breast cancer	6.54e-06	5.34e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CAV1—breast cancer	6.54e-06	5.33e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—breast cancer	6.48e-06	5.28e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SYNJ2—breast cancer	6.47e-06	5.28e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—IDH1—breast cancer	6.39e-06	5.21e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA1—breast cancer	6.39e-06	5.21e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NAT2—breast cancer	6.32e-06	5.15e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CG—breast cancer	6.29e-06	5.13e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—breast cancer	6.23e-06	5.08e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—breast cancer	6.2e-06	5.05e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—breast cancer	6.04e-06	4.92e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NDUFS3—breast cancer	6.02e-06	4.91e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CG—breast cancer	5.96e-06	4.86e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CAV1—breast cancer	5.75e-06	4.69e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—breast cancer	5.72e-06	4.66e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—breast cancer	5.69e-06	4.64e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CHST9—breast cancer	5.66e-06	4.61e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—DPYD—breast cancer	5.54e-06	4.52e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MED12—breast cancer	5.54e-06	4.52e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CD—breast cancer	5.53e-06	4.51e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALB—breast cancer	5.46e-06	4.45e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALDOA—breast cancer	5.46e-06	4.45e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—breast cancer	5.45e-06	4.44e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—COX11—breast cancer	5.36e-06	4.37e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOA3—breast cancer	5.3e-06	4.32e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC2A2—breast cancer	5.26e-06	4.29e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CD—breast cancer	5.24e-06	4.27e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CG—breast cancer	5.24e-06	4.27e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NOS3—breast cancer	5.22e-06	4.26e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALB—breast cancer	5.17e-06	4.22e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTR—breast cancer	5.15e-06	4.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCG2—breast cancer	5.15e-06	4.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CPT1A—breast cancer	5.15e-06	4.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HPGDS—breast cancer	5.05e-06	4.12e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—breast cancer	5.02e-06	4.1e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HBA1—breast cancer	5.02e-06	4.09e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NOS3—breast cancer	4.95e-06	4.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SHMT1—breast cancer	4.9e-06	4e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CDA—breast cancer	4.9e-06	4e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTT1—breast cancer	4.9e-06	4e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ACHE—breast cancer	4.9e-06	4e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CB—breast cancer	4.82e-06	3.93e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—breast cancer	4.81e-06	3.92e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—breast cancer	4.78e-06	3.9e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLCO1B1—breast cancer	4.72e-06	3.85e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC2A5—breast cancer	4.72e-06	3.85e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP17A1—breast cancer	4.64e-06	3.78e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CD—breast cancer	4.6e-06	3.75e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS1—breast cancer	4.59e-06	3.74e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ENO1—breast cancer	4.59e-06	3.74e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CB—breast cancer	4.57e-06	3.72e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APRT—breast cancer	4.56e-06	3.72e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALB—breast cancer	4.54e-06	3.71e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—breast cancer	4.54e-06	3.7e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—breast cancer	4.52e-06	3.69e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2D6—breast cancer	4.5e-06	3.67e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOA2—breast cancer	4.42e-06	3.6e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NOS3—breast cancer	4.35e-06	3.54e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ESRRA—breast cancer	4.29e-06	3.5e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ANGPTL4—breast cancer	4.29e-06	3.5e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—FASN—breast cancer	4.29e-06	3.5e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BCHE—breast cancer	4.27e-06	3.48e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC5A5—breast cancer	4.22e-06	3.44e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTEN—breast cancer	4.17e-06	3.4e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC2A1—breast cancer	4.07e-06	3.32e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NQO1—breast cancer	4.07e-06	3.32e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPI—breast cancer	4.06e-06	3.31e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HADHB—breast cancer	4.06e-06	3.31e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CB—breast cancer	4.01e-06	3.27e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—breast cancer	3.98e-06	3.24e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP3A4—breast cancer	3.97e-06	3.24e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTEN—breast cancer	3.95e-06	3.22e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—breast cancer	3.93e-06	3.21e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1B1—breast cancer	3.9e-06	3.18e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.88e-06	3.16e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.88e-06	3.16e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HSP90AA1—breast cancer	3.83e-06	3.12e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOA1—breast cancer	3.72e-06	3.04e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PHGDH—breast cancer	3.72e-06	3.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UMPS—breast cancer	3.72e-06	3.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ADSL—breast cancer	3.72e-06	3.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FHL2—breast cancer	3.72e-06	3.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NME1—breast cancer	3.72e-06	3.03e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—STK11—breast cancer	3.67e-06	2.99e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP19A1—breast cancer	3.67e-06	2.99e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LDHB—breast cancer	3.65e-06	2.97e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BRIP1—breast cancer	3.65e-06	2.97e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HPSE—breast cancer	3.65e-06	2.97e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTEN—breast cancer	3.47e-06	2.83e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA3—breast cancer	3.46e-06	2.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HMMR—breast cancer	3.46e-06	2.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCC1—breast cancer	3.46e-06	2.82e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—COMT—breast cancer	3.41e-06	2.78e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTP1—breast cancer	3.4e-06	2.77e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HMOX1—breast cancer	3.35e-06	2.73e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.35e-06	2.73e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ITPR1—breast cancer	3.34e-06	2.73e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCB1—breast cancer	3.22e-06	2.62e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA9—breast cancer	3.16e-06	2.58e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA4—breast cancer	3.16e-06	2.58e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMS—breast cancer	3.16e-06	2.57e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLA2G4A—breast cancer	3.12e-06	2.55e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOR1—breast cancer	3.12e-06	2.55e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—breast cancer	3.12e-06	2.55e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPX2—breast cancer	3.08e-06	2.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA2—breast cancer	3.08e-06	2.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPX4—breast cancer	3.04e-06	2.48e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SULT1A1—breast cancer	3.04e-06	2.48e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPX1—breast cancer	2.99e-06	2.44e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—IDH1—breast cancer	2.97e-06	2.42e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA1—breast cancer	2.97e-06	2.42e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1A1—breast cancer	2.96e-06	2.41e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—breast cancer	2.94e-06	2.4e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NAT2—breast cancer	2.94e-06	2.4e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ERCC2—breast cancer	2.93e-06	2.39e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—breast cancer	2.78e-06	2.27e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—breast cancer	2.76e-06	2.25e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—DPYD—breast cancer	2.58e-06	2.1e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MED12—breast cancer	2.58e-06	2.1e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CAV1—breast cancer	2.54e-06	2.07e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDOA—breast cancer	2.54e-06	2.07e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOA3—breast cancer	2.46e-06	2.01e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—breast cancer	2.45e-06	1.99e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC2A2—breast cancer	2.44e-06	1.99e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—breast cancer	2.4e-06	1.96e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CPT1A—breast cancer	2.4e-06	1.95e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTR—breast cancer	2.4e-06	1.95e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCG2—breast cancer	2.4e-06	1.95e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HPGDS—breast cancer	2.35e-06	1.92e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HBA1—breast cancer	2.33e-06	1.9e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CG—breast cancer	2.32e-06	1.89e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ACHE—breast cancer	2.28e-06	1.86e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTT1—breast cancer	2.28e-06	1.86e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—breast cancer	2.27e-06	1.85e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP17A1—breast cancer	2.16e-06	1.76e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ENO1—breast cancer	2.13e-06	1.74e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS1—breast cancer	2.13e-06	1.74e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2D6—breast cancer	2.09e-06	1.71e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOA2—breast cancer	2.06e-06	1.68e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CD—breast cancer	2.04e-06	1.66e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALB—breast cancer	2.01e-06	1.64e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—breast cancer	2e-06	1.63e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FASN—breast cancer	1.99e-06	1.63e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BCHE—breast cancer	1.98e-06	1.62e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC5A5—breast cancer	1.96e-06	1.6e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NOS3—breast cancer	1.92e-06	1.57e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NQO1—breast cancer	1.89e-06	1.54e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.89e-06	1.54e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.82e-06	1.48e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.78e-06	1.45e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CB—breast cancer	1.78e-06	1.45e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—breast cancer	1.76e-06	1.43e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOA1—breast cancer	1.73e-06	1.41e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.71e-06	1.39e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—STK11—breast cancer	1.71e-06	1.39e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—COMT—breast cancer	1.59e-06	1.29e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTP1—breast cancer	1.58e-06	1.29e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HMOX1—breast cancer	1.56e-06	1.27e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ITPR1—breast cancer	1.55e-06	1.27e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTEN—breast cancer	1.53e-06	1.25e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCB1—breast cancer	1.49e-06	1.22e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMS—breast cancer	1.47e-06	1.2e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOR1—breast cancer	1.45e-06	1.18e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—breast cancer	1.45e-06	1.18e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.45e-06	1.18e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPX1—breast cancer	1.39e-06	1.13e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.38e-06	1.12e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ERCC2—breast cancer	1.36e-06	1.11e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—breast cancer	1.28e-06	1.05e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CAV1—breast cancer	1.18e-06	9.65e-06	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—breast cancer	1.08e-06	8.83e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.08e-06	8.79e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CD—breast cancer	9.47e-07	7.72e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALB—breast cancer	9.35e-07	7.63e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NOS3—breast cancer	8.95e-07	7.29e-06	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—breast cancer	8.84e-07	7.21e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CB—breast cancer	8.26e-07	6.73e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—breast cancer	8.18e-07	6.67e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTEN—breast cancer	7.13e-07	5.82e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—breast cancer	5.03e-07	4.1e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—breast cancer	4.11e-07	3.35e-06	CbGpPWpGaD
